PE20050342A1 - Tableta que contiene el ester etilico de acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino]-propionico o sus sales - Google Patents
Tableta que contiene el ester etilico de acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino]-propionico o sus salesInfo
- Publication number
- PE20050342A1 PE20050342A1 PE2004000786A PE2004000786A PE20050342A1 PE 20050342 A1 PE20050342 A1 PE 20050342A1 PE 2004000786 A PE2004000786 A PE 2004000786A PE 2004000786 A PE2004000786 A PE 2004000786A PE 20050342 A1 PE20050342 A1 PE 20050342A1
- Authority
- PE
- Peru
- Prior art keywords
- methyl
- hexyloxicarbonylamino
- phenylamine
- imino
- pyridin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UNA TABLETA QUE COMPRENDE (a) EL ESTER ETILICO DEL ACIDO 3-[(2-{[4-(HEXILOXICARBONILAMINO-IMINO-METIL)-FENILAMINO]-METIL}-1-METIL-1H-BENCIMIDAZOL-5-CARBONIL)-PIRIDIN-2-IL-AMINO]-PROPIONICO Y (b) UNO O VARIOS ACIDOS ORGANICOS, FARMACEUTICAMENTE ACEPTABLES, CON UNA SOLUBILIDAD EN AGUA DE >1g/250ml A 20°C. EL CONTENIDO DE (a) EN LA TABLETA ES DE 5% A 50%. LOS ACIDOS ORGANICOS PREFERIDOS SON ACIDO TARTARICO, ACIDO FUMARICO, ACIDO SUCCINICO, ACIDO CITRICO, ENTRE OTROS. ESTA FORMULACION TIENE UN EFECTO INHIBIDOR DE TROMBINA Y ES UTIL EN LA PROFILAXIS POSTOPERATORIA DE TROMBOSIS VENOSAS PROFUNDAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10337697A DE10337697A1 (de) | 2003-08-16 | 2003-08-16 | Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20050342A1 true PE20050342A1 (es) | 2005-06-17 |
Family
ID=34201585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2004000786A PE20050342A1 (es) | 2003-08-16 | 2004-08-13 | Tableta que contiene el ester etilico de acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino]-propionico o sus sales |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050038077A1 (es) |
EP (1) | EP1658056B1 (es) |
JP (1) | JP4977462B2 (es) |
AR (1) | AR045732A1 (es) |
AT (1) | ATE394094T1 (es) |
CA (1) | CA2535810C (es) |
CY (1) | CY1108218T1 (es) |
DE (2) | DE10337697A1 (es) |
DK (1) | DK1658056T3 (es) |
ES (1) | ES2307041T3 (es) |
PE (1) | PE20050342A1 (es) |
PL (1) | PL1658056T3 (es) |
PT (1) | PT1658056E (es) |
SI (1) | SI1658056T1 (es) |
TW (1) | TW200509996A (es) |
UY (1) | UY28468A1 (es) |
WO (1) | WO2005018615A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
DE102005020002A1 (de) * | 2005-04-27 | 2006-11-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
JP2009543842A (ja) * | 2006-07-17 | 2009-12-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 心臓血管分野における直接トロンビン阻害薬のための新規適応 |
RU2010143901A (ru) * | 2008-03-28 | 2012-05-10 | Бёрингер Ингельхайм Интернациональ Гмбх (De) | Способ получения композиций дабигатрана для перорального введения |
NZ589746A (en) * | 2008-07-14 | 2012-10-26 | Boehringer Ingelheim Int | Method for manufacturing medicinal compounds containing dabigatran |
EP2309985B1 (en) * | 2008-07-28 | 2018-03-14 | Takeda Pharmaceutical Company Limited | Pharmaceutical composition |
HUP1000069A2 (en) * | 2010-02-02 | 2012-05-02 | Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag | New salts for the preparation of pharmaceutical composition |
WO2011110478A1 (en) | 2010-03-08 | 2011-09-15 | Ratiopharm Gmbh | Dabigatran etexilate-containing pharmaceutical composition |
US20130177652A1 (en) | 2010-07-01 | 2013-07-11 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical oral dosage forms comprising dabigatran etexilate and its pharmaceutically acceptable salts |
KR20200003219A (ko) | 2011-05-20 | 2020-01-08 | 아스트라제네카 유케이 리미티드 | 로수바스타틴 칼슘의 약학 조성물 |
EA201391758A1 (ru) | 2011-05-24 | 2014-06-30 | Тева Фармасьютикал Индастриз Лтд. | Спрессованная сердцевина для фармацевтической композиции, содержащая органические кислоты |
CN102391250B (zh) * | 2011-08-29 | 2013-06-19 | 石药集团欧意药业有限公司 | 一种达比加群酯化合物、制备方法及其药物组合物 |
RS62566B1 (sr) * | 2012-02-21 | 2021-12-31 | Towa Pharmaceutical Europe S L | Oralne farmaceutske kompozicije dabigatran eteksilata |
WO2014001220A1 (en) | 2012-06-25 | 2014-01-03 | Boehringer Ingelheim International Gmbh | Method for prevention of stroke |
SG11201501043TA (en) | 2012-09-19 | 2015-04-29 | Taiho Pharmaceutical Co Ltd | Pharmaceutical composition for oral administration with improved dissolution and/or absorption |
WO2014060561A1 (en) * | 2012-10-19 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Oral pharmaceutical formulations comprising dabigatran |
WO2014060545A1 (en) * | 2012-10-19 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Pharmaceutical compositions of dabigatran free base |
CN103230378B (zh) * | 2013-05-10 | 2014-12-10 | 青岛双鲸药业有限公司 | 一种氯雷他定片的制备方法 |
EP2853260A1 (en) * | 2013-09-27 | 2015-04-01 | ratiopharm GmbH | Pharmaceutical preparation comprising dabigatran etexilate bismesylate |
CN104784147B (zh) * | 2014-01-20 | 2018-01-23 | 成都苑东生物制药股份有限公司 | 一种甲磺酸达比加群酯胶囊药物组合物及其制备方法 |
WO2015145462A1 (en) | 2014-03-26 | 2015-10-01 | Cadila Healthcare Limited | Pharmaceutical compositions of dabigatran |
WO2016107605A1 (zh) * | 2014-12-31 | 2016-07-07 | 昆明积大制药股份有限公司 | 药物组合物及其制备方法 |
WO2017103945A1 (en) * | 2015-12-15 | 2017-06-22 | Strides Shasun Limited | Pharmaceutical compositions |
WO2017111637A1 (en) | 2015-12-23 | 2017-06-29 | Zaklady Farmaceutyczne Polpharma Sa | Pharmaceutical composition comprising dabigatran or a pharmaceutically acceptable salt thereof |
WO2018104387A1 (en) | 2016-12-07 | 2018-06-14 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Multilayered tablet compositions of dabigatran |
JP2018104425A (ja) * | 2016-12-26 | 2018-07-05 | 日本ケミファ株式会社 | ダビガトランエテキシラートまたはその薬学的に許容される塩を含有する錠剤 |
JP2018184375A (ja) * | 2017-04-27 | 2018-11-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法 |
TR201706848A2 (tr) | 2017-05-10 | 2018-11-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dabigatran eteksi̇lat i̇çeren kati oral farmasöti̇k kompozi̇syonlar |
WO2019004980A2 (en) | 2017-05-10 | 2019-01-03 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE |
TR201722323A2 (tr) | 2017-12-27 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dabi̇gatranin oral farmasöti̇k kompozi̇syonlari |
TR201722186A2 (tr) | 2017-12-27 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dabi̇gatranin farmasöti̇k kompozi̇syonlari |
TR201722630A2 (es) | 2017-12-28 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
KR880002139B1 (ko) * | 1983-04-08 | 1988-10-17 | 베링거 인겔하임 리미티드 | 경구 투여용 정제의 제조방법 |
WO1988000051A1 (en) * | 1986-06-24 | 1988-01-14 | Racz Istvan | Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability |
FR2745500B1 (fr) * | 1996-03-04 | 1998-04-03 | Synthelabo | Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine |
PE121699A1 (es) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
DE10133786A1 (de) * | 2001-07-16 | 2003-02-06 | Boehringer Ingelheim Pharma | Verwendung von Thrombin-Inhibitoren zur Behandlung von Arthritis |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
PL210862B1 (pl) * | 2002-03-07 | 2012-03-30 | Boehringer Ingelheim Pharma | Kompozycja farmaceutyczna w postaci peletki do doustnego podawania i sposób wytwarzania kompozycji |
DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
-
2003
- 2003-08-16 DE DE10337697A patent/DE10337697A1/de not_active Withdrawn
-
2004
- 2004-07-29 US US10/901,809 patent/US20050038077A1/en not_active Abandoned
- 2004-08-10 SI SI200430739T patent/SI1658056T1/sl unknown
- 2004-08-10 PT PT04763952T patent/PT1658056E/pt unknown
- 2004-08-10 WO PCT/EP2004/008934 patent/WO2005018615A1/de active IP Right Grant
- 2004-08-10 JP JP2006523572A patent/JP4977462B2/ja active Active
- 2004-08-10 DK DK04763952T patent/DK1658056T3/da active
- 2004-08-10 ES ES04763952T patent/ES2307041T3/es active Active
- 2004-08-10 CA CA2535810A patent/CA2535810C/en not_active Expired - Fee Related
- 2004-08-10 AT AT04763952T patent/ATE394094T1/de active
- 2004-08-10 EP EP04763952A patent/EP1658056B1/de active Active
- 2004-08-10 DE DE502004007069T patent/DE502004007069D1/de active Active
- 2004-08-10 PL PL04763952T patent/PL1658056T3/pl unknown
- 2004-08-13 UY UY28468A patent/UY28468A1/es not_active Application Discontinuation
- 2004-08-13 TW TW093124426A patent/TW200509996A/zh unknown
- 2004-08-13 PE PE2004000786A patent/PE20050342A1/es not_active Application Discontinuation
- 2004-08-13 AR ARP040102904A patent/AR045732A1/es unknown
-
2008
- 2008-07-28 CY CY20081100781T patent/CY1108218T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2307041T3 (es) | 2008-11-16 |
EP1658056A1 (de) | 2006-05-24 |
ATE394094T1 (de) | 2008-05-15 |
PL1658056T3 (pl) | 2008-10-31 |
DK1658056T3 (da) | 2008-09-08 |
TW200509996A (en) | 2005-03-16 |
PT1658056E (pt) | 2008-06-23 |
JP2007502788A (ja) | 2007-02-15 |
JP4977462B2 (ja) | 2012-07-18 |
EP1658056B1 (de) | 2008-05-07 |
DE502004007069D1 (en) | 2008-06-19 |
WO2005018615A1 (de) | 2005-03-03 |
DE10337697A1 (de) | 2005-03-24 |
UY28468A1 (es) | 2005-03-31 |
AR045732A1 (es) | 2005-11-09 |
SI1658056T1 (sl) | 2008-08-31 |
CY1108218T1 (el) | 2014-02-12 |
CA2535810A1 (en) | 2005-03-03 |
CA2535810C (en) | 2013-06-25 |
US20050038077A1 (en) | 2005-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20050342A1 (es) | Tableta que contiene el ester etilico de acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino]-propionico o sus sales | |
CR7865A (es) | Derivados de dihidropiranoindol -3,4-diona sustituidos y derivados de 2-hidroximetilindol del acido 3-oxoacetico sustituidos como inhibidores del inhibidor del activador del plasminogeno 1(pai-1) | |
ES2117034T3 (es) | Composicion para la limpieza de vidrio. | |
PE20060298A1 (es) | Derivados de acido carboxilico de bencimidazolona | |
PE20061153A1 (es) | Compuestos heterociclicos como inhibidores del factor viia | |
NO20043587L (no) | Nye heterocykliske forbindelser som er aktive som inhibitorer av beta-laktamaser | |
DOP2013000023A (es) | Un compuesto seleccionado del acido 6-(4-bromo-2-cloro-fenilamino) -7-fluror-3-metil-3h-benzoimidazol -5-carboxilico (2-hidroxi-etoxi)-amida y sales farmaceuticamente aceptables del mismo, y composiciones farmaceuticas que contienen dicho compuesto | |
ES2571779T3 (es) | Inhibidores de cinasa a base de nicotinamida | |
CO5600999A2 (es) | Composiciones farmaceuticas que comprenden inhibidores de valsartan y endopeptidasa neutra | |
AR060991A1 (es) | Acidos carboxilicos sustituidos con 4,5-difenilpirimidinilo y composiciones farmaceuticas que los contienen utilizadas para el tratamiento de la diabetes | |
BR0316583A (pt) | Derivados de ácido acético 3-alquil e 3-arilalquil 1h-indol-1-il substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1) | |
CO5611149A2 (es) | Forma de presentacion para administracion por vial oral, que comprende ester etilico de acido 3-[(2-{[4-(hexiloxicarbonilo amino-imino-metil)-fenilamino]-metil}-1-metil-1h-bencilimi dazol-5-carbonil)-piridin-2-il-amino]-propionico y un nucleo que com | |
MX2008009705A (es) | Composiciones farmaceuticas que contienen docetaxel, un inhibidor de degradacion y un proceso para obtener el mismo. | |
PE20081344A1 (es) | Inhibidores del virus de la hepatitis c | |
NO20005237L (no) | Heterocyklisk substituerte amider anvendt som calpain- inhibitorer | |
CR9694A (es) | Inhibidores de la transcriptasa reversa de vih | |
AR045490A1 (es) | Glucopiranosiloxi - pirazoles, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparacion | |
AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
ES2102668T3 (es) | Composiciones detergentes liquidas que contienen proteasa y ciertos acidos y esteres beta-aminoalquilboronicos. | |
PE20071321A1 (es) | Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados | |
UY25044A1 (es) | Utilizacion de inhibidores selectivos directos o indirectos del factor xa solos o en combinacion con un compuesto antiagregante plaquetario y composiciones destinadas a prevenir y tratar las enfermedades tromboembólicas arteriales | |
NO20083836L (no) | N-hydroksyakrylamidforbindelser | |
PE20080370A1 (es) | Derivados de quinazolinona como antagonistas de cgrp | |
CL2003002611A1 (es) | Compuestos derivados del acido tiofeno hidroxamico, 2-hidroxamida-5-[(aril o heteroaril)-disutituido-metil]-amida del acido tiofeno-2,5-dicarboxilico enantiomeros, composicion farmaceutica, procedimiento de preparacion, y su uso para el tratamiento d | |
CO5160323A1 (es) | Formulaciones farmaceuticas mejoradas vir en combinacion con otros inhibidores de proteasa vih |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |